BioWorld Asia

Jan. 1, 2003

French, Chinese Researchers Make Progress In SIV Treatment

Ardana, Columbia Enter Alliance To Develop Vaginal Gel Product

UK Government Steps In To Provide Huntingdon Insurance

Founders Staying In Israel As Keryx Moves Operations To U.S.

Other News To Note

Proteome Sciences, Biosite Align To Use Proteomics In Diagnostics

Proteome Sciences plc claimed it would be the first to commercialize a product based on proteomics when it announced a deal to use its protein biomarkers for stroke in point-of-care diagnostic equipment. (Bioworld International) Read More

Axovan, Biolipox Collaborate On GPCR-Binding Drug Discover

Today's news in brief

BioWorld

BioWorld briefs for Dec. 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 23, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.